Abstract
This study draws lessons from the resource mobilization experiences of the Global Polio Eradication Initiative (GPEI). As the GPEI launched its eradication effort in 1988, it underestimated both the difficulty and the costs of the campaign. Advocacy for resource mobilization came as an afterthought in the late 1990s, when achieving eradication by the target date of 2000 began to look doubtful. The reality of funding shortfalls undercutting eradication leads to the conclusion that advocacy for resource mobilization is as central to operations as are scientific and technical factors.
In 1988, the World Health Assembly (WHA) passed a resolution calling upon the world community to eradicate polio by the year 2000.1 Together with Rotary International, the United Nations Children’s Fund (UNICEF), and the U.S. Centers for Disease Control and Prevention (CDC), the World Health Organization (WHO) launched the Global Polio Eradication Initiative (GPEI) in 1988. Since then, millions of health workers and volunteers have been mobilized to provide the Oral Polio Vaccine (OPV) to billions of children, and the incidence of polio paralysis has been reduced by 99% around the globe. In spite of this enormous effort, eradication has remained elusive, and GPEI deadlines have come and gone twice. This article seeks to draw lessons from the advocacy work that kept the money flowing in the face of increasing needs and a constantly receding horizon.
As of November 2009, the official projection for certifying the world polio-free is 2013, 25 years after the 1988 resolution and 13 years after the original target date, with no certainty that even 2013 is attainable. One informant involved with the GPEI suggested that no one was prepared for the prolonged eradication effort and the spiraling costs that made resource mobilization such a challenge. In 1988, the cost estimates to secure eradication by 2000 totaled U.S.$1 billion (Bart, Foulds, & Patriarca, 1996; Informant-9, 2009), and the U.S.$100 million annual cost figure for polio eradication remained static through the mid-1990s (Cochi, Hull, & Ward, 1995). Numerous unforeseen factors drove up costs. Volunteer vaccinators were replaced by those receiving per diems. Vaccine refusal, increasing vaccine prices, armed conflicts, political instability, health system decentralization, deterioration of health care delivery, and related declines in routine immunization challenged eradication planners and drove up costs (Fields, 2009). The GPEI projections for 2013 now suggest total expenditures of U.S.$7.2 billion over the life of the effort.
In hindsight, it is clear that the GPEI until late in the initiative underestimated the costs of eradication, the funds needed from donors, and the centrality of resource mobilization to the success of eradication. Funding shortfalls at critical junctures (1999-2005) had a negative impact on the GPEI efforts, underscoring the conclusion that advocacy for resource mobilization is as central to operational feasibility as are science and technical solutions.
The advocacy messages used by the GPEI tended to be overly optimistic and glossed over criticisms of eradication or countered criticism with arguments that have grown harder to sustain. The program’s need for increasing levels of funding seems to have encouraged overly optimistic statements about the achievability of deadlines even in the face of contrary evidence. In addition, the publicity surrounding the resource mobilization campaign directed toward the Group of Seven/Group of Eight (G7/G8) and smaller Western countries inadvertently may have played into perceptions that polio eradication was a Western-driven and not a truly global priority. This plays out as a fairly pervasive belief in endemic countries that priority should be given to other diseases such as malaria and measles, which have higher perceived mortality, morbidity, and cost implications.
It is important to recognize at the outset that decisions were made in the context of the knowledge available at the time. None of the findings or questions raised in this study is intended to take away from the commitment, the dedication, and the many substantive accomplishments of those who have led the effort to eradicate polio and who have mobilized the resources required to do so. While it can be said that a lack of sufficient resources has plagued the program and may have contributed to missed deadlines, it also has been, according to informants, a remarkable achievement of unprecedented resource mobilization for global health.
Research Methodology
Sources for this study have included numerous publications and unpublished reports of the GPEI partners and working groups, partner internal documents, hundreds of print media articles in donor and polio-infected countries, secondary sources, and interviews with key polio eradication stakeholders. Most interviewees asked to speak on the condition of anonymity. The WHO/GPEI in Geneva declined a request for an interview.
Setting and Missing the 2000 Goal
In setting the goal of polio eradication by the year 2000 with certification 3 years after the last case, the WHA was buoyed by the important strides made by the Pan American Health Organization (PAHO) toward achieving polio eradication in the Americas. In 1985, under the leadership of Brazilian epidemiologist Ciro de Quadros, the PAHO launched an initiative to eradicate polio from the Western Hemisphere by the year 1990 (Fujimura, 2005). The striking success of mass immunization of children in Brazil and Cuba, using National Immunization Days (NIDs), showed the feasibility of eradication and established technical methods that could be applied to the global effort.
The global movement to eradicate polio also came on the heels of the successful, comparatively inexpensive, and relatively short-lived (under 10 years) smallpox eradication campaign. Smallpox eradication succeeded in large measure because there were a number of highly favorable characteristics that facilitated eradication, including a very heat-stable vaccine that protected with a single dose. No other disease came close to matching these advantages (Henderson, 1998). The idea of ridding the world of a second disease generated impassioned advocacy, as evidenced by the testimony of Rotary International polio eradication advocate Herbert Pigman before a subcommittee of the U.S. Senate Appropriations Committee in 1998: “Humankind is on the threshold of victory against Polio, and we must not miss this window of opportunity. Poliomyelitis will be the second major disease in history to be eradicated, but not the last” (Pigman, 1998).
The setting of the year 2000 goal was rich in symbolic value. The 1988 WHA Resolution indicates that the date “represents both a fitting challenge…and an appropriate gift, together with the eradication of smallpox, from the twentieth to the twenty-first century.” The architects of the 1988 resolution also believed that achieving eradication by a specified date would help assure that the GPEI would be spared the fatigue that inevitably would result if the eradication campaign were to extend over a longer period of time (Quadros, 2009)—one of the lessons learned from the failure of the costly effort to eradicate malaria that began in 1955 and was called off in 1970 (Prothero, 2003; Scholtens, Kaiser, & Langmuir, 1972).
A former United Nations (UN) agency official involved in the GPEI believes that the goal setting for polio eradication was likely a miscalculation:
Our technical communities wanted to serve up the silver bullet and make promises to get near-time resources without thinking about the long-term consequences of losing credibility on missing dates. The issue is, with 20-20 hindsight, did you really need a polio eradication goal to make long-term sustainable progress on polio elimination and possibly even eradication? (Informant-5, 2009)
The failure to attain successive target dates has tested the GPEI’s credibility among diverse audiences, including donors, and, according to informants, discouraged many around the globe who had rallied to the goal of achieving eradication by 2000. Despite the missed target dates, the GPEI continued to attract substantial amounts of funding, possibly because the size of past investments and early public statements of support seemed to incline major donors to continue to pursue eradication. One donor country official discounted the influence of GPEI global advocacy efforts on donors:
To some extent our decision on funding is a product of the fact that we’re in so deep already; the sense is that we can’t tell the public we spent billions, and we didn’t do what we set out to do. For me, that’s a much more powerful motivation than any sort of advocacy I’ve seen from GPEI. (Informant-2, 2009)
The Slow Start: From Country Level to Global Advocacy
Two early implementation decisions delayed the design of GPEI’s resource mobilization strategy, and the delay led to future setbacks in the eradication effort, including the failure to meet the 2000 goal. First, based on experiences in the Western Hemisphere, the 1989 Plan of Action sought to secure “high-level national commitment to the program and to ensure that personnel and resources are made available” (G8 Research Group, 2006). The Plan of Action was intended for polio-endemic countries, which was valid and necessary. By the second half of the 1990s, however, the GPEI partners realized they had underestimated the resource requirements and overestimated the capacity of lower-income countries to cover eradication costs, and so they gave greater emphasis to mobilizing resources from donors.
Second, in expanding polio eradication beyond the Western Hemisphere, the GPEI first focused on regions with stronger health infrastructures and only later turned to the more challenging areas, including sub-Saharan African (Informant-7, 2009). The following factors created an environment for rapid success in the first regions: political commitment to high-quality polio campaigns, effective routine immunization systems, trust in government-provided health services, and the capacity to find innovative solutions required to eliminate pockets of transmission (backed by substantial technical assistance from the GPEI). Countries in more challenging regions proved more difficult due to their weaker health infrastructures, fewer human and financial resources (e.g., to reach all underserved, minority, or nomadic areas), limited ability to address local conflicts or counter rumors about vaccine safety, or all of these conditions (Letor, 1998; WHO, Regional Office for Europe, 2001).
There are valid reasons for delaying programs in difficult operational environments, including the need to establish baseline information and build surveillance and laboratory capacity (Informant-7, 2009). There is also merit in looking for quick wins to build momentum. Since the most difficult areas also may be those where social and political challenges are more likely to threaten implementation, and waiting may only make the threats worse and costs higher, however, decision-making on where and when to start a program should consider political as well as health factors. An argument can be made that the longer a public health initiative requiring mass social mobilization takes, the more likely the effort will encounter unexpected social and political developments, both in endemic countries and globally.
The decision to first start in the “easiest” environments meant that the credibility of the main advocacy message about the achievability of eradication by 2000 was not tested in the more difficult operational environments until quite late in the game, and it also contributed to the relatively late recognition of resource underestimation. By the mid-1990s program managers recognized that earlier resource projections fell far short because they failed to appreciate the difficulty of the effort required to carry out large-scale eradication campaigns, especially in countries with poorly developed systems to support routine immunization (Informant-9, 2009). The long-term challenge of resource mobilization came to pose a threat to the entire eradication effort in the period 1999-2003, as eradication costs skyrocketed and funding shortfalls emerged (Lahariya, 2007).
The limited resources used for polio eradication from 1988 through 1995, as well as the burgeoning costs after 1995 as the GPEI encountered difficulties and as assistance to resource-poor countries increased (WHO, 2009). Annual expenditure, 1988-2008; financial resource requirements, contributions, funding gap, 2009-2013.
Rotary Takes the Lead in Responding to Growing Resource Demands
In the 1980s, Rotary International had adopted polio eradication as a global humanitarian cause that could be achieved by the time of the organization’s centennial in 2005. A far-flung international volunteer organization of business and professional leaders that in 2009 consisted of more than 32,000 service clubs and 1.5 million members in 166 countries, Rotary’s prominent and successful role in the mobilization of human and financial resources for polio eradication is unique in the global public health arena (Anonymous, 2005; Pigman, 2005; Rotary International Foundation, n.d.).
From the beginning, Rotary saw its commitment as complementing the work of UNICEF, WHO, and other major players. With concurrence of its partners, it made the decision in 1995 to increase its advocacy efforts in response to the anticipated gap caused by growing resource demands. The organization budgeted U.S.$3 million over 5 years to launch two major advocacy initiatives: the PolioPlus Partners Program and the Ad Hock Task Force on International Advocacy. PolioPlus sought to involve Rotarians in target countries in social mobilization, assistance to polio laboratories, and support to polio medical officers/epidemiologists. Most relevant for this study, the Ad HocTask Force on International Advocacy’s aim was to convince donor governments to increase their financial support for polio eradication. Rotary reported that this advocacy campaign resulted in increased contributions of more than U.S.$135 million. Rotary also was instrumental in securing the involvement of private sector partners—for instance, Coca Cola support in several African to “Kick Polio Out of Africa” (Rotary International Foundation, 1997).
Also in 1995, Rotary took the lead in articulating a strategy of media outreach to influence government leaders in donor countries and their constituencies (Rotary International Foundation, 1996). Prior to this, there had been little or no media coverage of GPEI within donor or potential donor countries. A survey of leading U.S. newspapers including the New York Times, Washington Post, and Boston Globe revealed that only one article was published on global polio eradication in the period 1990 through 1995. Once Rotary (and, later, other GPEI partners) began to engage the media, polio eradication enjoyed more frequent coverage in these major U.S. newspapers as well as in newspapers in other donor countries. In the United States, this helped create the enabling environment and momentum that contributed to Rotary’s success in securing U.S. government funding to launch, for instance, USAID’s GPEI in 1996.
Accelerating Polio Eradication Activities and the Growing Challenge of Resource Mobilization
In 1998, GPEI’s Technical Consultative Group expressed its “deep concern that the resources needed to complete the eradication task had not yet been identified” and said looming shortfalls constituted “the single greatest obstacle to global eradication” (Global Technical Consultative Group, 1998). In a race to meet the 2000 target, the GPEI had adopted a new strategy, and additional resources were desperately needed to carry out expanded and accelerated activities, including increased rounds of NIDs and a house-to-house vaccine delivery strategy designed to enable vaccination teams to find and immunize more children (WHO, 2001a).
The polio partners responded by intensifying their global advocacy effort. A new GPEI management team took charge in 1998 at WHO headquarters with a mandate to revitalize the eradication effort and mobilize additional resources. Canadian physician and epidemiologist Bruce Aylward led the team; he soon gained a reputation for being a tireless and passionate champion of global polio eradication.
At this time, GPEI also named WHO and UNICEF as the lead partners in donor advocacy and announced its intention to launch a “global communication campaign” aimed at donor governments, health ministries and political leaders in polio-endemic countries, private companies, development banks such as the World Bank, UN agencies, and the general public. The new resource mobilization campaign defined five core messages:
- Polio eradication is within reach.
- With peace, political commitment, and extra resources, we can meet the target.
- It will be a phenomenal achievement—both in terms of data and human interest.
- Eradication will bring health, economic, and peace dividends, in the form of access, partnership, savings, and truces.
- It is a platform for preventive health services.
UNICEF sponsored a meeting of polio partners that focused on social mobilization and donor advocacy, and the WHO published its first guide for polio advocacy, Advocacy: A Practical Guide With Polio Eradication as a Case Study, which detailed appropriate messages targeting key global, national, and local stakeholders (WHO, 1999a).
By 1999, GPEI found new partners in the Bill and Melinda Gates Foundation and the UN Foundation. Beyond the monetary resources these two foundations brought to the table, their commitments engendered confidence with other donors that polio eradication was attainable (Informant-2, 2009).
A U.S.$1 million gift from the UN Foundation enabled the WHO to hire, for the first time, a full-time advocacy officer in 2001 (WHO/GPEI, 2001). The new hire was tasked with developing and implementing a plan to sustain the political commitment to eradication, keeping high-level UN officials and Heads of States involved, and identifying polio advocacy opportunities for senior WHO and UNICEF executives (WHO/GPEI, 2002b). An informant close to GPEI/Geneva said that WHO advocacy on behalf of GPEI became more successful with the creation of this position (Informant-1, 2009), raising the question of how the polio eradication initiative might have evolved differently if WHO had earlier demonstrated greater commitment to global advocacy. The UN Foundation also set aside U.S.$5 million to enable Rotary to solicit funds from new, non-Rotarian private sector donors—an approach that reportedly was not very successful (Informant-5, 2009). The Gates Foundation has been active in advocating for financial commitments from donors and encouraging countries to increase their own funding toward eradicating polio. The Gates Foundation continued as a major donor to GPEI, providing its first contribution ($50 million) in 1999, and through 2008 it had committed a total of $400 million (Bill and Melinda Gates Foundation, n.d.).
Core Advocacy Arguments: Health System Strengthening
From the outset, the GPEI used its potential to foster health system strengthening to help justify the expenditure on polio eradication. In the PAHO-led eradication effort in the Americas, systems strengthening had been a core component and had proved essential to promoting a sense of national ownership of polio eradication (Quadros, 2009). As a result, the 1988 WHA global polio eradication resolution emphasized that “efforts to eradicate poliomyelitis serve to strengthen other immunization and health services.”
The GPEI used systems strengthening arguments in their advocacy to assuage concerns that polio eradication would divert funds from other public health investments, including routine immunization (Bart et al., 1996). The WHO pointed out that general immunization coverage had been stagnating or declining in many countries since 1990 and that polio eradication offered many opportunities to turn this around through improved surveillance, stronger cold chains, and better trained health staff:
The excitement generated by polio eradication and the consequent achievements have heightened visibility of immunization and increased political support for immunization programmes. Heightened political support often translates into an increase in the national budget for immunization. (WHO, 1998, p. 7)
In 2000, a WHO-commissioned report, Meeting on the Impact of Targeted Programmes on Health Systems: A Case Study of the Polio Eradication Initiative, refuted the argument that the initiative was undermining basic services but also called into question GPEI’s health systems strengthening assertions:
Polio eradication does not automatically have a positive health systems impact, nor grave disruption or diversion. Commonly the studies found mixed positive and negative effects, with no firm conclusion in either direction. (WHO, 2000)
The report also found that GPEI had “missed opportunities” to help strengthen the health care systems in targeted countries (WHO, 2000). Bruce Aylward seems to have been aware of the problematic nature of the health strengthening argument. In 2003, he cautioned that “proponents of future worldwide health goals should recognize the challenge of measuring such indirect [health and system strengthening] benefits, be modest in arguing their worth, and ensure there are agreed indicators and the capacity and mechanisms for their monitoring” (Aylward, Acharya, England, Agocs, & Linkins, 2003). After 2000, GPEI added to its advocacy messaging the extra health benefits of integrating the administration of vitamin A into polio NIDs. According to the WHO, the joint polio-vitamin A approach proved “to be a cost-effective strategy for reaching millions of children suffering from vitamin A deficiency, … , helping to avert an estimated 240,000 deaths” (WHO, 2001b).
Even after the evidence supporting the systems strengthening argument had been challenged, the argument remained central in GPEI’s advocacy. It made the case that “instead of competing with the primary health care services, the eradication program fosters the development of primary health care through a focused approach and the strengthening of managerial and other capacities of the primary health care system.” In time, the emphasis on the broader capacity of the GPEI-supported surveillance system seems to have emerged as the core systems strengthening argument. According to the WHO GPEI 2008 annual report, “of the 999 WHO immunization staff in the AFR [African Region], for example, 914 (91%) are funded by the polio programme, with the vast majority spending a considerable proportion of their time on work related to immunization, surveillance and outbreak response” (WHO/GPEI, 2008, p. 9). While it is undeniable that polio-funded staff spends time on related activities, the exact contribution to system strengthening remains undefined and unmeasured.
Core Advocacy Arguments: Cost Benefit
The cost benefits of polio eradication also emerged as a central tenet in GPEI’s advocacy toolkit. Eradication advocates persuasively argued that the public health strategy of disease eradication offered considerable advantages over disease control, noting that the benefits of eradication would be permanent and would accrue long after the finite costs of eradication ceased, while the costs of controlling the same disease must be maintained indefinitely (Bart et al., 1996). For high-income countries that already had eradicated polio, GPEI cited the savings to be attained through the cessation of routine polio immunizations as a resource-mobilization strategy. In 1996, USAID projected that eradication costs of U.S.$100 million per year worldwide would be a sound investment when compared with the then-current costs of U.S.$230 million per year for vaccinating U.S. children alone (USAID, 1996).
The cost-benefit advantage of eradication was a persuasive argument because eradication expenditures were temporary while control costs accrue ad infinitum. As long as eradication continued to be perceived as a feasible goal, it had to be conceded that it would be cost-effective over time (Hoel, 2007; Thompson & Duintjer Tebbens, 2007).
Rotary used the cost-benefit analysis of smallpox eradication to make the case with the U.S. Congress that polio eradication was a wise investment (Pigman, 1998). The point of the message was that it was not only developing countries that would reap the benefits, but the developed countries would benefit greatly because they would no longer have to keep vaccinating their populations once eradication occurred. Rotary may have inadvertently contributed to an impression, however, that eradication was being pursued globally because it was financially advantageous to developed countries. Such arguments fed perspectives in developing countries that polio eradication reflected a Western-driven agenda rather than the priorities of developing countries, where mortality and morbidity rates indicated that priority should be given to other diseases such as malaria and measles (Informant-1, 2009; Knippenberg, 1996; Renne, 2006).
More Obstacles on the Home Stretch
As the 2000 target for eradication approached, advocates began using slogans such as “the home stretch” and “final push” to motivate existing and untapped donors to fill recurrent funding gaps. The GPEI faced numerous problems, such as inadequate surveillance (including the absence of cross-border surveillance systems), low routine immunization coverage, and poor-quality NIDs, and difficulty reaching children (especially in conflict zones; UNICEF, 2000). In conflict-ridden countries, the costs of immunizing a child during NIDs could be two to three times higher than elsewhere. Furthermore, weak health infrastructures in many countries necessitated that staff be trained, cold chains be refurbished, transportation be improved, and program communication be strengthened–further driving up eradication costs (WHO, 1999b). Ironically, the policy of rapid acceleration was working, and the resulting increase in demand for vaccine had created additional challenges when OPV manufacturing capacity proved insufficient. According to GPEI, however, lack of funding compromised the quality of polio surveillance (especially in Africa), reduced the speed and quality of emergency outbreak response, and hindered the implementation of activities in key reservoir areas (WHO, 2000).
All of these factors put increasing pressure on the GPEI to secure sufficient funding to meet growing demand and to address a widening array of often-costly obstacles. Then, in late 2002, a number of partners did not provide expected year-end resources, resulting in an acute funding gap for 2003. This led to a revised strategic approach and a significant scaling back of activities and staff (WHO, 2003).
The Funding Gap Poses a Threat
With the acceleration of the eradication effort and skyrocketing resource demands, the GPEI adopted a “funding gap” argument in its advocacy to donors and potential donors. In 2001 UNICEF Director Carol Bellamy noted, “A $400 million funding gap posed a great threat to the program,” although she expressed confidence that the new 2005 target date for certifying the world polio-free was still within reach (UN News Center, 2001). In 2002, the Technical Consultative Group (TCG) stressed that the funding gap “constitutes the greatest threat” to polio eradication and that “closing the funding gap should be the highest priority of the partnership.” For 2002-2005, the TCG projected a U.S.$1 billion requirement with a U.S.$275 million shortfall (WHO/GPEI, 2002a). For its part, USAID challenged the accuracy of these projections, arguing that resource requirements were actually much higher (Ogden, 2001). The GPEI partners also began to face the possibility that the failure to reach goals, the requests for more funding, and competing international health priorities might undermine support for eradication.
In response, GPEI’s advocacy experts advised, “When approaching national leaders and possible donors, polio messages need to be integrated with other public health issues to minimize the fatigue factor and avoid overloading leaders with too many issues-for-action” (UNICEF, 2002). Press coverage in the eight U.K. and U.S. media houses analyzed as part of this study frequently repeated GPEI’s core funding gap message. Indeed, their reportage read much like expanded WHO press releases.
This favorable, unquestioning coverage would change, however, after the missed 2005 target, when dissident voices began to emerge from within the international health community. D. A. Henderson, who headed WHO’s smallpox eradication effort, said that “the siren song of eradication” had led public health authorities to declare goals he considered more “evangelical” than attainable. Dr. Julian Lob-Levyt, Executive Secretary of the Global Alliance for Vaccines and Immunisation (GAVI), contended that increased mobility of people and chaos in places like Sudan and Somalia make eradication harder today. “We are not talking about eradication the way we used to,” he said (McNeil & Dugger, 2006). In response, leading GPEI spokespersons assumed a more defensive posture as to the feasibility of eradication.
One result of the funding gap argument was that the focus was directed to donors’ failure to provide the resources required for success rather than to the need to respond to programmatic and technical weaknesses and social and political factors in endemic countries.
In packaging its funding gap messages, the GPEI highlighted commitments from international donors but rarely mentioned the contributions in money or in-kind made by countries carrying out polio eradication activities. One question for future programs is to what extent the lack of reference in WHO/GPEI publications to contributions by “host” countries may have fed into local perceptions that polio eradication reflected a Western-driven agenda (Renne, 2006). In the age of the Internet, material targeting one audience is available to virtually all, and publications prepared by WHO Geneva targeting international donors are accessible to diverse audiences. A clearer indication of the contribution made by affected countries may have helped foster the perception of GPEI as a truly global initiative and may have contributed to strengthening the sense of national ownership of the eradication initiative. This sense of national ownership over the polio eradication initiative was a factor in its success in the Americas (Quadros, 2009).
The Polio Advocacy Group and the G8
Faced with an officially acknowledged U.S.$275 million shortfall and questions about the attainability of the 2005 eradication goal, in 2002 the GPEI created a structure known as the Polio Advocacy Group (PAG). This interagency group was mandated to coordinate international advocacy and resource mobilization activities across the polio eradication partnership. Consisting of external relations, resource mobilization, and communications experts from WHO, UNICEF, the UN Foundation, and Rotary, the PAG set its sights on the G8 summits and declarations as a mechanism to further lobby donor governments to fill the funding gaps (UNICEF, 2002).
At the 2002 G8 Summit in Kananaskis, Canada, the G8 nations committed to provide sufficient resources to eliminate polio by 2005. Thereafter, the PAG began to focus attention on appeals and personal visits to translate the G8’s commitment to the GPEI into firmer monetary pledges. From 2003 to 2005, the G8 nations pledged successively higher dollar amounts to meet the GPEI’s requirements and committed its member states to the overall goal of global polio eradication (G8 Research Group, 2006; WHO, 2003). Between 2006 to 2008, that is, after GPEI missed its 2005 target date for eradication, however, G8 funding decreased by approximately 40%. Contribution from the United States remained steady, while all other G8 countries decreased their contributions (GPEI, 2007a). As a result, to implement the intensified eradication activities in 2007, traditional development partner financing had to be supplemented substantially by host country domestic funding, most notably from the Government of India, as well as a U.S.$ 104 million reprogramming of International Finance Facility for Immunization funds previously earmarked for a posteradication-era vaccine stockpile. Rotary International and the Bill and Melinda Gates Foundation also sought to fill the gap. In November 2007, they announced a partnership designed to inject U.S.$ 200 million into the GPEI over the next 4 years. The Gates Foundation awarded the Rotary Foundation one of its largest-ever challenge grants of U.S.$100 million, to be expended in 2008, with Rotary matching dollar-for-dollar over the next 3 years (GPEI, 2007b).
Outreach to Organization of Islamic Conference
By 2003, only seven countries were polio endemic. Only 784 cases of polio paralysis were reported worldwide for the entire year, an impressive accomplishment considering that in 1988 the caseload was more than a thousand people a day in 125 countries. In addition, three WHO regions had been certified polio-free: the Americas in 1994, the Western Pacific in 2000, and Europe in 2002.
But events in Nigeria and India derailed progress. Rumors that OPV deliberately had been laced with harmful substances such as antifertility agents (estradiol hormone), HIV, and cancerous agents posed challenges in many countries (UNICEF, 2002), but in predominately Muslim areas of Nigeria and India the impact of these rumors was particularly damaging.
In response, the GPEI began in 2003 to reach out to the Organization of the Islamic Conference (OIC) for political and financial support. The setbacks in majority-Muslim areas of Nigeria and India led many to argue that the previous success of other OIC members in eradicating polio could be used as positive examples of the benefits of polio immunization (Aylward, 2007).
The OIC passed a resolution in October 2003 urging an all-out effort to eradicate polio from the countries of the OIC still afflicted by it. The WHO worked to encourage religious leaders to publicly support polio eradication. Ambassadors from OIC countries were briefed in order to build political support (Kaufmann, 2008). This messaging was successful in the sense that it helped to soften Islamic opposition to vaccination in Nigeria (Soares, 2004).
Soon thereafter, Malaysia and the United Arab Emirates each made U.S.$1 million contributions to the eradication program. The GPEI advocates were disappointed, however, that the resource-rich Persian Gulf countries donated less than U.S.$3 million, falling short of the U.S.$250 million requested of them (Rosenstein, 2006).
Advocacy to the OIC took on new life in 2009. In July of that year, following U.S. President Barack Obama’s June speech in Cairo, Egypt, the United States and the OIC announced the formation of a partnership to eradicate polio within the framework of the GPEI (Bernama, 2009). OIC Secretary General Ekmeleddin Ihsanoglu echoed the themes of the Obama speech in Cairo:
Fighting Malaria and Polio has recently become an important priority for our organization. We are working hard for reconciliation between Islam and the West because we believe that today’s human civilization is one civilization with a multitude of tributaries and branches. (OIC, 2009)
In September 2009, on the eve of the fortieth anniversary of the OIC, Saudi Arabia pledged U.S.$30 million to support polio eradication (PRWeb, 2009).
The Stakes Are High: It’s Now or Never
As target dates were missed, heartening slogans such as “We are in the home stretch” were replaced by messages emphasizing the dire consequences of failing to achieve eradication: “The stakes are high; it is now or never.” Such messages suggested that the investment already made in polio eradication would be in vain and that progress in reversing the human toll of polio would be lost unless donors continued to invest in eradication. Jim Lacy, Chairman of the Rotary Foundation, said, “With so much at stake, we must not come this close and not finish successfully” (Altman, 2004). Bruce Aylward asserted:
This $3 billion investment in polio eradication since 1988 is really in jeopardy…. There is no such thing as a polio “control program.”…If you don’t get it finished now, you are not going to have 5,000 cases in five years—you are going to have 250,000 again. It will happen if we don’t finish it now. (Brown, 2003)
While GPEI continued to argue for eradication, some members of the international health community began to ask again if polio eradication was realistic and suggested the need to redefine success. They asserted that certain factors militated against successful eradication:
- changes in the global political landscape since the 1988 WHA resolution, which created social and political settings unfavorable to a vaccination campaign and sufficient levels of routine vaccination;
- the reality that the wild virus was known to survive even saturated vaccination campaigns such as those in northern India;
- the reversion of vaccine-derived virus to a wild form; and
- evidence that the virus can circulate undetected longer than previously known.
Konstantin Chumakov, Associate Director for Research, U.S. Food and Drug Administration, noted that there seemed to be no inclination among GPEI leadership to reassess whether an eradication campaign still made sense. They “press on as if nothing had happened, as if it were 1988.” Chumakov called them “captives of their own advertising.…Every year is the final one. This can’t continue forever.” He added that the program should be proud of what it has achieved, and the world should “declare victory now” (Roberts, 2006). Others called for a shift in the global strategy from “eradication” to “effective control” (Arita, Nakane, & Fenner, 2006).
A study on the economics of eradication released in 2007 suggested the following:
Focusing on the large costs for poliomyelitis eradication, without assessing the even larger potential benefits of eradication and the enormous long-term costs of effective control, might inappropriately affect commitments to the goal of eradication, and thus debate should include careful consideration of the options. (Thompson & Duintjer Tebbens, 2007)
The authors found that even more short-term eradication expenditures were necessary. They suggested that the intensity of immunization had to be increased to achieve eradication, and that even small decreases in intensity could lead to large outbreaks. Their findings implied the need to pay even higher short-run costs, even though this likely would further exacerbate concerns about continued investment in interventions that were perceived to be expensive in relationship to the outcomes. They concluded that a wavering commitment would lead to greater cumulative costs, many more cases, and a failure to eradicate (Thompson & Duintjer Tebbens, 2007).
The Final Push, Once Again
The study by Thompson and Duintjer Tebbens set the parameters for discussion of yet another “intensified effort” launched in 2008 to achieve eradication. In announcing the “new intensified eradication” effort, the WHO/GPEI opted this time, however, not to set a new target date for eradication. The 2008 GPEI strategy did, nonetheless, project resource requirements to achieve certification in 2012; in 2009, the projection was extended to 2013 (WHO, 2008, 2009). The truth of the matter is that international health experts are unable to predict the end of polio; newly projected eradication certification dates have come to reflect best-case scenarios for eradication under current approaches. The technical and scientific basis of eradication is undergoing constant review, and new approaches are being adopted. Operationally, the wild polio virus persists in very difficult regions of four especially challenging countries: Afghanistan, India, Nigeria, and Pakistan. With gaps in routine immunization and the export of virus from the endemic countries by 2008, the polio virus was found in 18 countries. The need to contain outbreaks in formerly polio-free countries is driving up costs. These dynamic factors make forecasting very difficult.
The GPEI estimated the cost of the “new intensified eradication” effort to be U.S.$1.306 billion, and in January 2008, the GPEI estimated its funding gap at U.S.$525 million. It estimated the financial requirements of certification and the posteradication period (2010-2012) to be U.S.$492 million (WHO, 2008). To help implement the new intensified eradication campaign, three endemic countries contributed substantial amounts, according to a rare GPEI announcement about the contributions made by target country governments: India set aside up to U.S.$226 million; Nigeria U.S.$22 million; and Pakistan U.S.$20 million. A year later, when the GPEI extended the timeline of certification to 2013, it increased the size of the estimated funding gap to U.S.$915 million out of a total requirement of U.S.$2.3 billion (WHO, 2009), which is roughly double the originally projected total cost of global eradication given in the 1990s (not discounting for inflation).
Given missed deadlines, remaining obstacles, and rising costs, resource mobilization remains a daunting challenge for the GPEI, and by mid-2009 there was mounting evidence of donor fatigue and publicly expressed doubts about the achievability of eradication. One foreign assistance official from a donor country expressed the following:
Our official position is we’re supportive of GPEI and committed, and we’ve made funding commitments. When it looks like polio will be an ongoing commitment, then we will have to look at morbidity rates for different diseases and cost-effectiveness. But that calculation didn’t figure too much in the debate when talking about eradication. If it’s an on-going thing, then it is conceptualized in a different way. (Informant-5, 2009)
Renewed political commitments from the heads of state and local leaders in the four endemic countries in late 2009 and early 2010 hold promise that the will is there to overcome the remaining obstacles and could be a compelling factor in sustaining donor funding in the most difficult last mile of this marathon. The GPEI funding estimates are revised quarterly and may increase based on the plan to introduce bivalent vaccine and accelerate activities in 2010-2012.
Considerations for Future Resource Mobilization Enterprises
The experiences of the GPEI provide valuable lessons for any future eradication or other international global health programs. The GPEI has been successful both in progress toward eradication and in resourcemobilization. These recommendations should be seen not as criticisms but, rather, as recognition that the GPEI has forged new ground from which future programs can learn and grow.
- Major public health initiatives should consider resource mobilization to be an integral component of their operations, on a par with technical and scientific aspects. Global advocacy and resource mobilization should be central to the assessment of operational feasibility. One of the first actions of any major global public health initiative should be to hire a professional global advocacy and resource mobilization staff to strengthen donor support and to secure commitments of adequate funding.
- The constant funding gaps experienced by the GPEI suggest that when starting a new global health effort, whether eradication or another goal, program managers must be realistic and open about resource requirements. It would be useful to include a range of time and cost estimates, from evidenced-based best- to worst-case scenarios. Such estimates should incorporate potential technical, implementation, and political difficulties that may change an optimistic target date. In general, challenges need to be thought through at the onset of an eradication program and messaging done in the context of the lifetime of the effort.
- It may be worthwhile to consider establishing a formal “devil’s advocate,” whether an individual or committee, whose function is to challenge preconceived notions and orthodoxies and avoid the perils of group think. Such a system, increasingly used by a variety of organizations, helps establish constructive accountability to ensure that the drive for success, the maintenance of enthusiasm and morale, and the demands of resource mobilization do not ignore alternative scenarios and responses.
- From the beginning, systems to report on expenditures, needs, pledges, and contributions should be established. The in-kind and financial contributions made by “host” countries should be included in reporting. This not only would encourage other recipient countries to make contributions but also could help counter the perception of the initiative as Western donor driven.
- Organizations such as the Global Fund to Fight Aids, Tuberculosis and Malaria have acknowledged the value of open and transparent financial reporting, allowing donors to see both how they compare with others and how their taxpayers’ funds are being spent.
- The longer a public health initiative requiring mass social mobilization takes, the more likely that the effort will encounter unexpected social and political developments capable of hindering the effort. While recognizing the need for quick wins, work must begin in the hardest regions as “proof of concept” early on to help ensure that projections accurately reflect real-life situations.
- To analyze the social and political landscape, which can adversely affect success, any new public health initiative should consider establishing from the outset multidisciplinary advisory bodies, at international, regional, and country level, that include not only epidemiologists and virologists, but also social scientists, communication and behavior change experts, diplomats/political experts, and regional and country experts. Two models might be the multisectoral and public/private Country Coordinating Mechanisms of the Global Fund or the Global Fund’s Technical Evaluation Reference Group (TERG). A strong team of skilled and multidisciplinary communication and behavior change experts can help lead, manage, and evaluate increasingly sophisticated outreach, geared to different audiences and purposes. This should be supported through separate line items in annual work plans and budgets.
- As suggested by Bruce Aylward, when formulating advocacy messages and justifications, proponents of future worldwide health goals should recognize the challenge of measuring indirect benefits, be modest in arguing their worth, and ensure there are agreed indicators and the capacity and mechanisms for their monitoring. The need for agreed indications and for monitoring and evaluation cannot be overstated.